Scivita Medical and Boston Scientific Deepen Strategic Collaboration to Advance Global Commercialization of Disposable Endoscopy Solutions

Recently, Scivita Medical Technology Co., Ltd. ("Scivita Medical") and Boston Scientific Corporation (NYSE: BSX), a global leading medical technology company, joined hands again to officially sign a strategic cooperation agreement.

Signing Ceremony Photo

Scivita Medical Technology Co., Ltd. X Boston Scientific Corporation Strategic Cooperation Signing Ceremony

With the iterative updates of endoscopic technology, endoscopes have evolved into interventional tools that integrate diagnosis and treatment. Single-use electronic endoscopes solve the issue of cross-infection prevalent in traditional endoscopy, and their penetration rate in the medical endoscope market will continue to increase in the future. According to statistics from Frost & Sullivan, the global market size for single-use medical endoscopes was $500 million in 2020 and is expected to grow to $9.2 billion by 2030.

As a minimally invasive diagnosis and treatment enterprise focusing on the research, development, and commercialization of medical endoscopes and related products, "globalization" has always been the strategic goal of Scivita Medical. Through strategic cooperation with local enterprises and multinational corporations such as Boston Scientific, Scivita Medical is continuously advancing towards this goal.

According to the agreement,Scivita Medical and Boston Scientific will further deepen their cooperative relationship in strategic joint research and development, as well as global promotion, including the co-development of next-generation endoscopic products and the global commercialization of their single-use endoscopes and imaging devices.It is expected that this deepened cooperation will help Scivita Medical accelerate its global pace and provide more comprehensive single-use endoscope overall solutions for doctors and patients in China and even globally.

Dr. Chen Dong (left), Co-founder, General Manager, and Chief Technology Officer of Scivita Medical Technology Co., Ltd.

Mike Jones (right), Global Senior Vice President of Boston Scientific, President of the Endoscopy and Respiratory Interventions Division

Mike Jones, Global Senior Vice President of Boston Scientific, President of Endoscopy and Respiratory Interventions Division"We are delighted to further deepen our partnership with Scivita Medical Technology Co., Ltd. This collaboration is expected to provide doctors around the world with more choices in endoscopic products. We also look forward to successfully strengthening our cooperative relationship through this new agreement."

Dr. Chen Dong, Co-founder, General Manager, and Chief Technology Officer of Scivita Medical Technology Co., Ltd.Stated: "We are very pleased to see the further deepening of our cooperation with Boston Scientific. As a global leading medical technology company, we believe that through this powerful collaboration, combining the core strengths of both companies, we can deliver high-quality, single-use endoscopy solutions to doctors and patients in more regions around the world. Partnering with international top-tier medical technology enterprises like Boston Scientific is an important part of Scivita Medical's globalization strategy. We will accelerate the speed of innovation and R&D, continuously expand innovative business cooperation models, and ensure that more innovative, high-quality, and accessible products benefit healthcare providers and patients worldwide."

Scivita Medical Founded in October 2016, is a minimally invasive diagnosis and treatment enterprise specializing in the research, development, and commercialization of medical endoscopes and related innovative products. The company's core development strategy is "Rooted in China, with a global perspective," and it has established research and development centers in both China and Japan. Relying on its strong independent R&D capabilities, Scivita Medical has built five core technology platforms and developed a comprehensive portfolio of medical endoscope products and products under research, covering all types of endoscopic surgeries performed across clinical departments in hospitals to meet the diverse needs of doctors and patients worldwide. Adhering to the corporate values of "Clinical Focus," "Collaborative Innovation," "People-Oriented," and "Excellence and Efficiency," Scivita Medical will continue to upgrade minimally invasive diagnosis and treatment technologies, increase market penetration through excellent product strength, and become the trusted preferred brand for doctors and patients globally.